These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12921230)

  • 41. Antihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002.
    Lopez J; Meier J; Cunningham F; Siegel D
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1095-9. PubMed ID: 15607614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current recommendations of the joint national high blood pressure committee.
    Carter BL
    Clin Pharm; 1993 Jan; 12(1):53-7. PubMed ID: 8428433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 44. Compliance with antihypertensive therapy: raising the bar of expectations.
    Rudd P
    Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polypharmacy and non-compliance in the hypertensive elderly patient.
    Fonseca T; Clara JG
    Rev Port Cardiol; 2000 Sep; 19(9):855-72. PubMed ID: 11109869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in pharmacologic management of hypertension in the United States.
    Manolio TA; Cutler JA; Furberg CD; Psaty BM; Whelton PK; Applegate WB
    Arch Intern Med; 1995 Apr; 155(8):829-37. PubMed ID: 7717791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of hypertension: insights from the JNC-VI report.
    Kaplan NM
    Am Fam Physician; 1998 Oct; 58(6):1323-30. PubMed ID: 9803197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oil and water? Economic advantage and biomedical progress do not mix well in a government guidelines committee.
    Ménard J
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):877-85. PubMed ID: 7826550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Physicians' view on drug therapy for hypertension. A questionnaire in the county of Hordaland].
    Smiseth OA; Horgen E; Eskerud J; Melsom H
    Tidsskr Nor Laegeforen; 1996 May; 116(13):1588-90. PubMed ID: 8685872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Individualized guidelines: the potential for increasing quality and reducing costs.
    Eddy DM; Adler J; Patterson B; Lucas D; Smith KA; Morris M
    Ann Intern Med; 2011 May; 154(9):627-34. PubMed ID: 21536939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic implications of evidence-based prescribing for hypertension: can better care cost less?
    Fischer MA; Avorn J
    JAMA; 2004 Apr; 291(15):1850-6. PubMed ID: 15100203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Competence of Polish primary-care doctors in the pharmacological treatment of hypertension.
    Windak A; Gryglewska B; Tomasik T; Narkiewicz K; Yaphe J; Grodzicki T
    J Eval Clin Pract; 2010 Feb; 16(1):25-30. PubMed ID: 20367812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meperidine utilization and compliance with Agency for Health Care Policy and Research guidelines in a tertiary care hospital.
    Pellegrini JE; Paice J; Faut-Callahan M
    CRNA; 1999 Nov; 10(4):174-80. PubMed ID: 10723296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.
    Naiman DJ; Barker LR
    Md Med J; 1999; 48(6):307-11. PubMed ID: 10628133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment.
    Wettermark B; Godman B; Neovius M; Hedberg N; Mellgren TO; Kahan T
    Health Policy; 2010 Mar; 94(3):221-9. PubMed ID: 19879009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of elderly health examination program: the example of hypertension screening.
    Deng BH; Liu HW; Pan PC; Mau LW; Chiu HC
    Kaohsiung J Med Sci; 2007 Jan; 23(1):17-24. PubMed ID: 17282981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adherence to hypertension treatment guidelines in state facilities in KwaZulu-Natal, South Africa.
    Cassimjee M; Suleman F
    J Eval Clin Pract; 2009 Dec; 15(6):1077-81. PubMed ID: 20367708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Principles of drug therapy in hypertension.
    Shetty MA; Hegde BM
    J Indian Med Assoc; 1999 Mar; 97(3):106-9. PubMed ID: 10652911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in health services utilization and costs between antihypertensive medication users versus nonusers in adults with diabetes and concomitant hypertension from Medical Expenditure Panel Survey pooled years 2006 to 2009.
    Davis-Ajami ML; Wu J; Fink JC
    Value Health; 2014; 17(1):51-61. PubMed ID: 24438717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacoutilization of antihypertensive drugs: a model of analysis.
    Degli Esposti E; Sturani A; Degli Esposti L; Macini PL; Falasca P; Valpiani G; Buda S
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):251-8. PubMed ID: 11430633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.